mxene academic
Column

Signal Transduction and Targeted Therapy | Activation of nerve growth factor signaling limits the response to lenvatinib in hepatocellular carcinoma
QQ Academic Group: 1092348845

Detailed

Resistance to lenvatinib remains a major obstacle in the treatment of advanced hepatocellular carcinoma (HCC), highlighting the urgency to elucidate its underlying mechani

return
Copyright © beijing beike new material Technology Co., Ltd 京ICP备16054715-2号